Brief: Lineage Cell Therapeutics Reports Quarterly Loss Per Share Of $0.03

Lineage Cell Therapeutics

12/03/2020 21:58

March 12 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE CELL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL
YEAR
2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * Q4 REVENUE $1.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$1
MILLION
    * ANTICIPATES NET OPERATIONAL SPEND FOR 2020 WILL BE ABOUT
$16
MILLION
    * QTRLY LOSS PER SHARE $0.03

Source text for Eikon:  ID:nBw9dR98Da 
Further company coverage:  LCTX.A 

 ((Reuters.Briefs@thomsonreuters.com;))